Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "antiviral drug"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Complete Sequence Analysis and Antiviral Screening of Medicinal Plants for Human Coxsackievirus A16 Isolated in Korea
Jae-Hyoung Song, Kwisung Park, Aeri Shim, Bo-Eun Kwon, Jae-Hee Ahn, Young Jin Choi, Jae Kyung Kim, Sang-Gu Yeo, Kyungah Yoon, Hyun-Jeong Ko
Osong Public Health Res Perspect. 2015;6(1):52-58.   Published online February 28, 2015
DOI: https://doi.org/10.1016/j.phrp.2014.12.004
  • 2,061 View
  • 17 Download
  • 15 Citations
AbstractAbstract PDF
Objectives
Coxsackievirus A group 16 strain (CVA16) is one of the predominant causative agents of hand, foot, and mouth disease (HFMD).
Methods
Using a specimen from a male patient with HFMD, we isolated and performed sequencing of the Korean CVA16 strain and compared it with a G10 reference strain. Also, we were investigated the effects of medicinal plant extract on the cytopathic effects (CPE) by CPE reduction assay against Korean CVA16.
Results
Phylogenetic analysis showed that the Korean CVA16 isolate belonged to cluster B-1 and was closely related to the strain PM-15765-00 isolated in Malaysia in 2000. The Korean CVA16 isolate showed 73.2% nucleotide identity to the G10 prototype strain and 98.7% nucleotide identity to PM-15765-00. Next, we assessed whether the Korean CVA16 isolate could be used for in vitro screening of antiviral agents to treat HFMD infection. Vero cells infected with the Korean CVA16 isolate showed a cytopathic effect 2 days after the infection, and the treatment of cells with Cornus officinalis, Acer triflorum, Pulsatilla koreana, and Clematis heracleifolia var. davidiana Hemsl extracts exhibited strong antiviral activity against CVA16.
Conclusion
Collectively, our work provides potential candidates for the development of vaccine and novel drugs to treat the CVA16 strain isolated from a Korean patient.

Citations

Citations to this article as recorded by  
  • Recent advances in anti-coxsackievirus A16 viral drug research
    Xiaolan Yuan, Ziwei Liu, Li Wan, Wei Liu, Yan Huang, Shuang Cao
    Future Medicinal Chemistry.2023; 15(1): 97.     CrossRef
  • A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy
    Nur Fadlin Saifulazmi, Emelda Rosseleena Rohani, Sarahani Harun, Hamidun Bunawan, Hamizah Shahirah Hamezah, Nor Azlan Nor Muhammad, Kamalrul Azlan Azizan, Qamar Uddin Ahmed, Sharida Fakurazi, Ahmed Mediani, Murni Nazira Sarian
    Life.2022; 12(8): 1287.     CrossRef
  • Medicinal plants: Treasure for antiviral drug discovery
    Sofi Imtiyaz Ali, Wajid Mohammad Sheikh, Muzafar Ahmad Rather, Venugopalan Venkatesalu, Showkeen Muzamil Bashir, Showkat Ul Nabi
    Phytotherapy Research.2021; 35(7): 3447.     CrossRef
  • Seasonal Distribution and Meteorological Factors Associated with Hand, Foot, and Mouth Disease among Children in Xi’an, Northwestern China
    Tianci Guo, Jifeng Liu, Junjiang Chen, Yao Bai, Yong Long, Baozhong Chen, Shuxuan Song, Zhongjun Shao, Kun Liu
    The American Journal of Tropical Medicine and Hyg.2020; 102(6): 1253.     CrossRef
  • Short-term effects of meteorological factors and air pollution on childhood hand-foot-mouth disease in Guilin, China
    Guoqi Yu, Yonghong Li, Jiansheng Cai, Dongmei Yu, Jiexia Tang, Wenwen Zhai, Yi Wei, Shiyi Chen, Quanhui Chen, Jian Qin
    Science of The Total Environment.2019; 646: 460.     CrossRef
  • The effect of temperature on childhood hand, foot and mouth disease in Guangdong Province, China, 2010–2013: a multicity study
    Zece Xu, Wenqi Hu, Kedi Jiao, Ci Ren, Baofa Jiang, Wei Ma
    BMC Infectious Diseases.2019;[Epub]     CrossRef
  • Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017
    Tianjiao Ji, Taoli Han, Xiaojuan Tan, Shuangli Zhu, Dongmei Yan, Qian Yang, Yang Song, Aili Cui, Yan Zhang, Naiying Mao, Songtao Xu, Zhen Zhu, Dandan Niu, Yong Zhang, Wenbo Xu
    Biosafety and Health.2019; 1(1): 32.     CrossRef
  • A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
    Ruixiao Du, Qunying Mao, Yalin Hu, Shuhui Lang, Shiyang Sun, Kelei Li, Fan Gao, Lianlian Bian, Ce Yang, Bopei Cui, Longfa Xu, Tong Cheng, Zhenglun Liang
    Human Vaccines & Immunotherapeutics.2019; 15(10): 2343.     CrossRef
  • Corni Fructus: a review of chemical constituents and pharmacological activities
    Yu Dong, Zhe-Ling Feng, Hu-Biao Chen, Fu-Sheng Wang, Jia-Hong Lu
    Chinese Medicine.2018;[Epub]     CrossRef
  • Inhibition of Murine Norovirus and Feline Calicivirus by Edible Herbal Extracts
    Dong Joo Seo, Changsun Choi
    Food and Environmental Virology.2017; 9(1): 35.     CrossRef
  • Antiviral activity of herbal extracts against the hepatitis A virus
    Dong Joo Seo, Minhwa Lee, Su Been Jeon, Hyunkyung Park, Suntak Jeong, Bog-Hieu Lee, Changsun Choi
    Food Control.2017; 72: 9.     CrossRef
  • A novel Enterovirus 96 circulating in China causes hand, foot, and mouth disease
    Yi Xu, Yisuo Sun, Jinmin Ma, Shuru Zhou, Wei Fang, Jiawei Ye, Limei Tan, Jingkai Ji, Dan Luo, Liqiang Li, Jiandong Li, Chunxiao Fang, Na Pei, Shuo Shi, Xin Liu, Hui Jiang, Sitang Gong, Xun Xu
    Virus Genes.2017; 53(3): 352.     CrossRef
  • Characterization of VP1 sequence of Coxsackievirus A16 isolates by Bayesian evolutionary method
    Guolian Zhao, Xun Zhang, Changmin Wang, Guoqing Wang, Fan Li
    Virology Journal.2016;[Epub]     CrossRef
  • Traditional uses, phytochemistry, and pharmacology of the genus Acer (maple): A review
    Wu Bi, Ying Gao, Jie Shen, Chunnian He, Haibo Liu, Yong Peng, Chunhong Zhang, Peigen Xiao
    Journal of Ethnopharmacology.2016; 189: 31.     CrossRef
  • Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland China
    Zhi-Chao Zhuang, Zeng-Qiang Kou, Yong-Juan Bai, Xiang Cong, Li-Hong Wang, Chun Li, Li Zhao, Xue-Jie Yu, Zhi-Yu Wang, Hong-Ling Wen
    Viruses.2015; 7(12): 6400.     CrossRef
Articles
The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season
Woo-Young Choi, Inseok Yang, Sujin Kim, Namjoo Lee, Meehwa Kwon, Joo-Yeon Lee, Chun Kang
Osong Public Health Res Perspect. 2011;2(3):178-185.   Published online December 31, 2011
DOI: https://doi.org/10.1016/j.phrp.2011.11.042
  • 2,033 View
  • 13 Download
  • 10 Citations
AbstractAbstract PDF
Objectives
To monitor antiviral drug resistance among seasonal influenza viruses isolated in Korea during the 2008-2009 influenza season, we examined influenza isolates collected through Korea Influenza Surveillance Scheme for antiviral drug susceptibility.
Methods
For genetic analysis of antiviral drug resistance, the matrix (M2) and neuraminidase (NA) genes of each isolate were amplified by reverse transcription-polymerase chain reaction and followed by nucleotide sequencing. For phylogenetic analyses, the sequences of hemagglutinin (HA) and NA genes of each isolate were aligned using multiple alignment program. For phenotypic analysis of antiviral drug resistance, drug susceptibilities against M2 inhibitor (amantadine) and NA inhibitors (oseltavimir and zanamivir) were determined by virus yield reduction assay and fluorometric NA inhibition assay, respectively.
Results
In Korea, the resistant influenza viruses against oseltamivir were first detected in sealsonal influenza A(H1N1) viruses on Week 48 of 2008. Since then, the number of oseltamivir-resistant A(H1N1) viruses was continuously increased and had reached the highest peak on Week 52 of 2008. 533 (99.8%) of 534 A(H1N1) viruses were resistant to oseltamivir and all of them harbored the H275Y mutation in the NA gene during the 2008-2009 season. The oseltamivir resistance identified by sequencing was confirmed by NA inhibition assay. Genetic analysis based on HA gene of the resistant A(H1N1) viruses revealed that the viruses were identified as A/Brisbane/10/2007-like strain which was vaccine strain for the 2008-2009 season.
Conclusions
The oseltamivir-resistant A(H1N1) viruses were first emerged in Europe in November 2007 and then circulated globally. One year later, the oseltamivir-resistant A(H1N1) viruses were first detected in Korea in November 2008 and continued circulating until the Week 7 of 2009 during the 2008-2009 season. Considering the pandemic preparedness, it should be continued to monitor the emergence and the characterization of antiviral drug resistant influenza viruses.

Citations

Citations to this article as recorded by  
  • Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects
    Yun Kim, Sangwon Lee, Yohan Kim, In‐Jin Jang, SeungHwan Lee
    Clinical and Translational Science.2022; 15(2): 422.     CrossRef
  • 2018–2019 antiviral drug sensitivity of the influenza virus strains isolated from various regions of Kazakhstan
    T. I. Glebova, N. G. Klivleyeva, G. V. Lukmanova, N. T. Saktaganov, A. M. Baimukhametova
    Russian Journal of Infection and Immunity.2021; 11(6): 1159.     CrossRef
  • Assessment of Intensive Vaccination and Antiviral Treatment in 2009 Influenza Pandemic in Korea
    Chaeshin Chu, Sunmi Lee
    Osong Public Health and Research Perspectives.2015; 6(1): 47.     CrossRef
  • Doing Mathematics with Aftermath of Pandemic Influenza 2009
    Hae-Wol Cho, Chaeshin Chu
    Osong Public Health and Research Perspectives.2015; 6(1): 1.     CrossRef
  • Antiviral treatment of influenza in South Korea
    Young June Choe, Hyunju Lee, Hoan Jong Lee, Eun Hwa Choi
    Expert Review of Anti-infective Therapy.2015; 13(6): 741.     CrossRef
  • Synthesis and anti-influenza virus activity of 4-oxo- or thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones
    Ye Jin Jang, Raghavendra Achary, Hye Won Lee, Hyo Jin Lee, Chong-Kyo Lee, Soo Bong Han, Young-Sik Jung, Nam Sook Kang, Pilho Kim, Meehyein Kim
    Antiviral Research.2014; 107: 66.     CrossRef
  • Was the Mass Vaccination Effective During the Influenza Pandemic 2009–2010 in Korea?
    Hae-Wol Cho, Chaeshin Chu
    Osong Public Health and Research Perspectives.2013; 4(4): 177.     CrossRef
  • How to Manage a Public Health Crisis and Bioterrorism in Korea
    Hae-Wol Cho, Chaeshin Chu
    Osong Public Health and Research Perspectives.2013; 4(5): 223.     CrossRef
  • Generation and Characterization of Recombinant Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
    WooYoung Choi, Jin-Young Shin, Hwan-Eui Jeong, Mi-Jin Jeong, Su-Jin Kim, Joo-Yeon Lee, Chun Kang
    Osong Public Health and Research Perspectives.2013; 4(6): 323.     CrossRef
  • Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
    Seoung Geun Kim, Yoon Ha Hwang, Yung Hae Shin, Sung Won Kim, Woo Sik Jung, Sung Mi Kim, Jae Min Oh, Na Young Lee, Mun Ju Kim, Kyung Soon Cho, Yeon Gyeong Park, Sang Kee Min, Chang Kyu Lee, Jun Sub Kim, Chun Kang, Joo Yeon Lee, Man Kyu Huh, Chang Hoon Kim
    Korean Journal of Pediatrics.2013; 56(4): 165.     CrossRef

PHRP : Osong Public Health and Research Perspectives